Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2024 · 90 positions · Total reported value $746.58M · Top-10 concentration 35.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Parkman Healthcare Partners LLC disclosed 90 equity positions with a combined reported value of $746.58M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were BSX ($42.48M), PODD ($36.18M), UTHR ($35.48M). By sector, the heaviest allocations are Health Care 83.1%, Industrials 0.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.1pp) and away from Industrials (-1.9pp), Other (-3.1pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q2 2024 were AGIO ($19.25M), MRK ($12.38M), ICLR ($11.62M).

Of the 13 positions fully exited versus the prior quarter, the largest were INSP ($17.44M), SILK ($15.55M), OSCR ($12.36M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • AGIO AGIOS PHARMACEUTICALS INC · $19.25M
  • MRK MERCK & CO INC · $12.38M
  • ICLR ICON PUB LTD CO · $11.62M
  • HUM HUMANA INC · $11.22M
  • GILD GILEAD SCIENCES INC · $8.58M
  • BMY BRISTOL-MYERS SQUIBB CO · $8.31M
  • ANAB ANAPTYSBIO INC · $6.42M
  • REPL REPLIMUNE GROUP INC · $4.72M

Fully Exited (vs previous quarter)

  • INSP INSPIRE MED SYS INC · prev qtr: $17.44M · history
  • SILK SILK RD MED INC · prev qtr: $15.55M
  • OSCR OSCAR HEALTH INC · prev qtr: $12.36M
  • HCA HCA HEALTHCARE INC · prev qtr: $11.77M
  • DCPH DECIPHERA PHARMACEUTICALS IN · prev qtr: $11.47M
  • TMO THERMO FISHER SCIENTIFIC INC · prev qtr: $9.05M
  • IRON DISC MEDICINE INC · prev qtr: $6.70M
  • CRL CHARLES RIV LABS INTL INC · prev qtr: $4.80M · history

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.1%
Other 16.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 551.59K $42.48M 5.69%
5.69%
Add
2 179.31K $36.18M 4.85%
4.85%
Add
3 111.38K $35.48M 4.75%
4.75%
Reduce
4 31.65K $28.66M 3.84%
3.84%
Reduce
5 308.40K $26.92M 3.61%
3.61%
Add
6 148.93K $19.81M 2.65%
2.65%
Reduce
7 446.42K $19.25M 2.58%
2.58%
New
8 694.18K $18.76M 2.51%
2.51%
Hold
9 296.74K $17.85M 2.39%
2.39%
Reduce
10 156.85K $17.78M 2.38%
2.38%
Reduce
11 68.17K $15.93M 2.13%
2.13%
Add
12 115.17K $15.86M 2.12%
2.12%
Reduce
13 27.75K $15.04M 2.01%
2.01%
Add
14 721.37K $13.95M 1.87%
1.87%
Reduce
15 185.03K $12.67M 1.70%
1.70%
Add
16 121.91K $12.67M 1.70%
1.70%
Hold
17 2.41M $12.58M 1.69%
1.69%
Hold
18 908.82K $12.52M 1.68%
1.68%
Add
19 100.00K $12.38M 1.66%
1.66%
New
20 600.70K $12.33M 1.65%
1.65%
Reduce
21 647.14K $12.08M 1.62%
1.62%
Hold
22 37.06K $11.62M 1.56%
1.56%
New
23 150.19K $11.34M 1.52%
1.52%
Hold
24 30.04K $11.22M 1.50%
1.50%
New
25 535.06K $10.83M 1.45%
1.45%
Add
26 574.52K $10.35M 1.39%
1.39%
Reduce
27 474.68K $9.91M 1.33%
1.33%
Add
28 234.27K $9.63M 1.29%
1.29%
Reduce
29 195.57K $9.42M 1.26%
1.26%
Add
30 198.63K $9.08M 1.22%
1.22%
Add
31 852.42K $8.91M 1.19%
1.19%
Add
32 156.84K $8.66M 1.16%
1.16%
Hold
33 595.39K $8.61M 1.15%
1.15%
Add
34 125.00K $8.58M 1.15%
1.15%
New
35 38.01K $8.56M 1.15%
1.15%
Reduce
36 200.00K $8.31M 1.11%
1.11%
New
37 209.29K $8.16M 1.09%
1.09%
Reduce
38 969.89K $7.97M 1.07%
1.07%
Hold
39 161.71K $7.71M 1.03%
1.03%
Add
40 256.31K $6.42M 0.86%
0.86%
New
41 141.38K $6.33M 0.85%
0.85%
Add
42 415.54K $6.33M 0.85%
0.85%
Add
43 76.08K $6.29M 0.84%
0.84%
Reduce
44 277.89K $6.05M 0.81%
0.81%
Reduce
45 353.94K $5.75M 0.77%
0.77%
Reduce
46 876.27K $5.71M 0.77%
0.77%
Add
47 289.84K $5.51M 0.74%
0.74%
Add
48 80.27K $5.38M 0.72%
0.72%
Reduce
49 447.62K $5.37M 0.72%
0.72%
Add
50 1.15M $5.36M 0.72%
0.72%
Reduce

FAQ

What did Parkman Healthcare Partners LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, Parkman Healthcare Partners LLC reported 90 equity positions worth $746.58M in aggregate; its largest disclosed positions were BSX ($42.48M), PODD ($36.18M), UTHR ($35.48M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $746.58M of long equity holdings across 90 positions as of 2024-Q2. Top-10 holdings account for 35.3% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →